General
Preferred name
CYCLOPENTHIAZIDE
Synonyms
Cyclomethiazide ()
Su-8341 ()
SU 8341 ()
NSC-107679 ()
Navidrex ()
P&D ID
PD013265
CAS
742-20-1
Tags
available
drug
Drug Status
approved
Max Phase
Phase 4
Drug indication
Antihypertensive
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION The drug used as cyclopenthiazide is a racemic mixture of (R)- and (S)-stereoisomers (PubChem CIDs 6604279 and 40463616 respectively). (GtoPdb)
Compound Sets
13
ChEMBL Approved Drugs
CHEMBL1373254
ChEMBL Drugs
CHEMBL1373254
DrugBank
DB13532
DrugBank Approved Drugs
DB13532
DrugCentral
756
DrugCentral Approved Drugs
756
DrugMatrix
Guide to Pharmacology
7899
MedChem Express Bioactive Compound Library
HY-109542
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
TargetMol Bioactive Compound Library
T21469
External IDs
30
Properties
(calculated by RDKit )
Molecular Weight
379.04
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
1
cLogP
1.6
TPSA
118.36
Fraction CSP3
0.54
Chiral centers
1.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data